Box score
AdvanCell, Inc.
Reported $218M sold in a new Form D filed July 16, 2026 (Cambridge, Massachusetts).
- Biggest raise
- $218M filed Jul 16, 2026
- League
- Bio & Health Biotechnology
- Based in
- Cambridge, Massachusetts
- Season rank
- #3 of 1,121 in the Bio & Health League; #93 of 10,745 overall (2026)
- Incorporated
- 2026
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-07-16 | New notice | $218M | $315M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2144758.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Solstice Oncology, Inc. rookie | Bio & Health | $121M |
| 2 | Climb Bio, Inc. | Bio & Health | $110M |
| 3 | Strand Therapeutics Inc. | Bio & Health | $108M |
| 4 | Alzheon, Inc. | Bio & Health | $78.8M |
| 5 | Ratio Therapeutics, Inc. | Bio & Health | $70M |
| 6 | Superluminal Medicines, Inc. | Bio & Health | $65.5M |